HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A Graziani Selected Research
A Graziani Research Topics
Disease
3
Neoplasms (Cancer)
04/2001 - 02/2001
2
Ischemia
02/2001 - 02/2000
1
Asthma (Bronchial Asthma)
11/2014
1
Intellectual Disability (Idiocy)
11/2014
1
Respiratory Insufficiency (Respiratory Failure)
11/2014
1
Churg-Strauss Syndrome (Allergic Angiitis)
11/2014
1
Genetic Predisposition to Disease (Genetic Predisposition)
11/2014
1
Neurodevelopmental Disorders
11/2014
1
Hypoxia (Hypoxemia)
06/2010
1
Reperfusion Injury
06/2010
1
Starvation
12/2003
1
Breast Neoplasms (Breast Cancer)
04/2001
1
Choriocarcinoma
03/2001
1
Pituitary ACTH Hypersecretion
02/2001
Drug/Important Bio-Agent (IBA)
3
hexarelin
IBA
04/2001 - 02/2000
1
Omalizumab (Xolair)
FDA Link
11/2014
1
Immunoglobulin E (IgE)
IBA
11/2014
1
Steroids
IBA
11/2014
1
Interleukin-6 (Interleukin 6)
IBA
11/2014
1
Cytokines
IBA
11/2014
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
11/2014
1
2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosine
IBA
06/2010
1
R 59949
IBA
06/2010
1
Adenosine A2A Receptor (Adenosine A2A Receptors)
IBA
06/2010
1
Small Interfering RNA (siRNA)
IBA
06/2010
1
Diglycerides
IBA
06/2010
1
Protein Kinase C
IBA
06/2010
1
Insulin-Like Peptides
IBA
12/2003
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2003
1
Ghrelin Receptors
IBA
04/2001
1
ibutamoren mesylate
IBA
04/2001
1
Ghrelin
IBA
04/2001
1
Messenger RNA (mRNA)
IBA
04/2001
1
Growth Hormone (Somatotropin)
IBA
04/2001
1
tyrosyl-alanyl-hexarelin
IBA
04/2001
1
Secretagogues
IBA
04/2001
1
Biological Products
IBA
04/2001
1
Peptides (Polypeptides)
IBA
03/2001
1
Tyrosine (L-Tyrosine)
FDA Link
03/2001
1
Oxytocin Receptors (Oxytocin Receptor)
IBA
03/2001
1
Proteins (Proteins, Gene)
FDA Link
03/2001
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
03/2001
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
02/2001
1
Hydrocortisone (Cortisol)
FDA Link
Generic
02/2001
Therapy/Procedure
1
Therapeutics
11/2014